Sector: Pharmaceuticals & Biotechnology

Small Cap

Lincoln Pharma Share Price

Lincoln Pharmaceuticals Ltd.

₹619

-3.60(-0.58%)

Trade Now

23rd Feb 2026 | 3:28 PM

NSE : LINCOLN

Open Free Demat Account

Lincoln Pharma Performance

Price Movement

₹619.00

₹610.10

₹621.05

↘ Today's Low↗ Today's High

1 Year Performance

₹619.00

₹440.00

₹677.00

↘ 52 Week Low↗ 52 Week High

Markets Today

High₹621.05

Low₹610.10

Open at₹620.00

Prev Close₹622.60

Volumes34.02 K

Avg Price₹617.67

Lower Circuit₹560.35

Upper Circuit₹684.85

Historical Performance

3M High₹677.00

3M Low₹440.00

1 Yr High₹677.00

1 Yr Low₹440.00

3 Yr High₹979.50

3 Yr Low₹319.25

5 Yr High₹979.50

5 Yr Low₹219.20

Lincoln Pharma Fundamentals

Market Cap

Above industry Median

1,239.50 Cr.

PE Ratio (TTM)

Below industry Median

14.10

Dividend Yield

Below industry Median

0.30

Net Profit TTM

2% decr over last year

87.83

Net Profit Growth

2% decr over last year

87.83

PEG Ratio

Negative PEG TTM

-8.20

ROE

22% decr over last year

12.25

Operating Revenue TTM

651.94

Operating Revenue Growth

9.1% incr over last year

Book Value

Below industry Median

1.70

MFI

MFI strongly Overbought

90.76

RSI

RSI is mid-range

69.60

EPS (TTM)

41.11

Debt to Equity

Face Value

Operating Profit Margin Qtr.

15.72

Operating Profit Qtr.

23.60

Net Profit Qtr.

28.60

Operating Revenue Qtr.

166.32

PB Ratio

1.70

Lincoln Pharma Financials

*All values are in Rs. Cr

Loading chart...

Indicator	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024
Total Revenue	166.32	163.36	154.07	168.18	146.55
Operating Expense	142.73	137.94	130.26	141.46	122.89
Operating Profit	23.60	25.43	23.80	26.72	23.66
Depreciation	3.72	3.62	3.48	3.23	3.22
Interest	0.30	0.23	0.21	0.37	0.73
Tax	6.12	8.83	7.71	4.67	7.91
Net Profit	28.60	19.98	27.68	11.58	20.77

Lincoln Pharma Technicals

Lincoln Pharmaceuticals Ltd. EMA & SMA

₹619.00

-3.60 (-0.58%)

↗ Bullish Moving Average

↘ Bearish Moving Average

Day EMA5 ₹617.7

Day EMA10 ₹592.2

Day EMA12 ₹582.4

Day EMA20 ₹553.7

Day EMA26 ₹540.5

Day EMA50 ₹519

Day EMA100 ₹517.5

Day EMA200 ₹538

Lincoln Pharma Support and Resistance

Resistance

First Resistance₹635.03

Second Resistance₹647.47

Third Resistance₹659.93

Support

First Support₹610.13

Second Support₹597.67

Third Support₹585.23

Technical Indicators

Day RSI69.60

Day MFI90.76

Day ADX48.45

Day Commodity Channel Index95.50

William-24.27

Day MACD41.98

Day MACD Signal Line28.76

Day ATR29.83

Day ROC12513.56

Day ROC2135.24

Lincoln Pharma Shareholding Pattern

Held By	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025
Promoter	49.8	49.8	49.8	49.8	49.8	49.8
FII	5.2	5.2	5	5.1	4.7	4.7
DII	0	0	0	0	0	0
Public	45	45.1	45.2	45.1	45.5	45.5

Lincoln Pharma Delivery And Volume

Period	Combined Delivery Volume	NSE+BSE Traded Volume Avg	Daily Avg Delivery Volume %
Day	17.46 K	27.64 K	63.15%
Week	34.6 K	55.15 K	62.74%
1 Month	56.77 K	1.36 L	41.81%
6 Month	20.7 K	42.03 K	49.26%

Lincoln Pharma SWOT Analysis

Strengths20

Weakness2

Opportunity3

Threats1

Companies with no Debt

Benjamin Graham Value Screen

Companies with 10% increase in share price over three months, with rising net profit growth

Strong Momentum: Price above short, medium and long term moving averages

Relative Outperformance versus Industry over 1 Month

Rising Net Cash Flow and Cash from Operating activity

PEG lower than Industry PEG

High Momentum Scores (Technical Scores greater than 50)

Relative Outperformance versus Industry over 1 Week

Relative Outperformance versus Industry over 1 Month

Overbought by Money Flow Index (MFI)

Growth in Net Profit with increasing Profit Margin (QoQ)

Increasing Revenue every quarter for the past 2 quarters

Strong cash generating ability from core business - Improving Cash Flow from operation for last 2 years

Company able to generate Net Cash - Improving Net Cash Flow for last 2 years

Book Value per share Improving for last 2 years

Companies with Zero Promoter Pledge

Stock gained more than 20% in one month

RSI indicating price strength

Stocks Outperforming their Industry Price Change in the Quarter

Lincoln Pharma Corporate Action

Ex-Date	Dividend Amount	Dividend Type	Record Date	Instrument Type
12 Sep, 2025	1.8	FINAL	12 Sep, 2025	Equity Share
13 Sep, 2024	1.8	FINAL		Equity Share
15 Sep, 2023	1.5	FINAL		Equity Share
15 Sep, 2022	1.5	FINAL		Equity Share
16 Sep, 2021	1.5	FINAL		Equity Share
05 Mar, 2020	1.5	INTERIM	06 Mar, 2020	Equity Share
19 Sep, 2019	1.5	FINAL		Equity Share
19 Sep, 2018	1.5	FINAL		Equity Share
21 Sep, 2017	1.2	FINAL		Equity Share
23 Sep, 2016	1	FINAL		Equity Share

Lincoln Pharma Stock Comparison

Financials	Vivimed Labs Ltd.	Amanta Healthcare Ltd.	Anlon Healthcare Ltd.	Amrutanjan Health Care Ltd.	Senores Pharmaceuticals Ltd.	Innova Captab Ltd.
Price (₹)	₹8.43	₹104	₹115.35	₹604	₹791.10	₹690
% Change	4.98%	-1.38%	-3.98%	-1.99%	-2.37%	3.06%
Revenue TTM (₹ Cr)	₹104.12	₹282.74	-	₹488.20	₹588.52	₹1,496.96
Net Profit TTM (₹ Cr)	₹-24.37	₹15.30	-	₹56.90	₹101.60	₹132.41
PE TTM	-2.90	26.50	-	30.70	36.00	29.60
1 Year Return	743	-17.19	27.77	0.89	41.16	-12.8
ROCE	-5.63	-	-	23.87	9.34	14.12

Similar Stocks

VALIANTLAB

Valiant Laboratories Ltd.

₹ 59.10

+1.37%

SIGACHI

Sigachi Industries Ltd.

₹ 21.22

-3.68%

WINDLAS

Windlas Biotech Ltd.

₹ 774.00

-0.82%

VINEETLAB

Vineet Laboratories Ltd.

₹ 31.51

-1.62%

SOLARA

Solara Active Pharma Sciences Ltd.

₹ 472.60

+0.23%

ZIMLAB

Zim Laboratories Ltd.

₹ 72.00

+1.72%

MEDICO

Medico Remedies Ltd.

₹ 48.00

+4.53%

DCAL

Dishman Carbogen Amcis Ltd.

₹ 182.40

+0.07%

LASA

Lasa Supergenerics Ltd.

₹ 8.05

+2.42%

ADVENZYMES

Advanced Enzyme Technologies Ltd.

₹ 313.00

+0.02%

BAJAJHCARE

Bajaj Healthcare Ltd.

₹ 348.00

-1.29%

ORTINGLOBE

Ortin Global Ltd.

₹ 18.91

-4.97%

BROOKS

Brooks Laboratories Ltd.

₹ 72.62

-2.48%

RPGLIFE

RPG Life Sciences Ltd.

₹ 1915.00

+0.59%

BAFNAPH

Bafna Pharmaceuticals Ltd.

₹ 111.50

-1.11%

ALPA

Alpa Laboratories Ltd.

₹ 68.45

+2.30%

SPARC

Sun Pharma Advanced Research Company Ltd.

₹ 127.75

-1.13%

SMSPHARMA

SMS Pharmaceuticals Ltd.

₹ 375.20

+0.74%

NECLIFE

Nectar Lifesciences Ltd.

₹ 12.70

+0.63%

MANGALAM

Mangalam Drugs and Organics Ltd.

₹ 31.15

-1.61%

INDOCO

Indoco Remedies Ltd.

₹ 200.10

+0.93%

INDSWFTLAB

Ind-Swift Laboratories Ltd.

₹ 146.60

+3.32%

PANACEABIO

Panacea Biotec Ltd.

₹ 338.80

-0.79%

FAQ's on LINCOLN

What is the current share price of Lincoln Pharmaceuticals Ltd.?

As of 6 June 2025 at 10:01 AM, the share price for Lincoln Pharmaceuticals Ltd. is ₹ 619 on the NSE and ₹ 619 on the BSE. (Note: Prices are dynamic and update frequently during market hours).

What is the Market Capitalization of Lincoln Pharmaceuticals Ltd.?

Market capitalization (market cap) represents the total market value of a company's outstanding shares based on its current share price. As of 6 June 2025, the market cap for Lincoln Pharmaceuticals Ltd. is approximately ₹ 1239.5 Cr.

What are the PE and PB ratios for Lincoln Pharmaceuticals Ltd.?

Based on recent data, the Price-to-Earnings (PE) ratio for Lincoln Pharmaceuticals Ltd. is 14.1, and the Price-to-Book (PB) ratio is 1.7.

What is the 52-Week High and Low for Lincoln Pharmaceuticals Ltd.?

Over the past 52 weeks, the highest price reached by Lincoln Pharmaceuticals Ltd. shares was ₹ 677, and the lowest price was ₹ 440.

What is the current dividend yield for Lincoln Pharmaceuticals Ltd.?

As of 6 June 2025, the dividend yield for Lincoln Pharmaceuticals Ltd. is 0.3%. The dividend yield is calculated based on the company's annual dividend payouts relative to its current share price.

Who are the major shareholders of Lincoln Pharmaceuticals Ltd.?

Significant shareholdings in Lincoln Pharmaceuticals Ltd. typically include entities such as:

Promoter
Public
FII
Other Institutions

(Note: Shareholding patterns can change; this represents major holders based on recent filings).

Who are the peers of Lincoln Pharmaceuticals Ltd. in the Pharmaceuticals & Biotechnology sector?

In the Pharmaceuticals & Biotechnology sector, Lincoln Pharmaceuticals Ltd. is often compared with other major players such as Accretion Nutraveda, Rekvina Laboratories, Vivimed Labs, Corona Remedies, Sudeep Pharma and Curis Lifesciences for analysis and benchmarking.

What is the latest dividend information for Lincoln Pharmaceuticals Ltd.?

Lincoln Pharmaceuticals Ltd. last declared a FINAL dividend of ₹ 1.8 per share for the financial period ending 2025. The record date was set as 2025-09-12, and the payment was/is scheduled around 2025-09-12. For the most current dividend announcements, refer to official company filings.

Invest Anytime, Anywhere

By signing up I certify terms, conditions & privacy policy